A Rare Penetrant TIMP3 Mutation Confers Relatively Late Onset Choroidal Neovascularisation Which Can Mimic Age-related Macular Degeneration
Overview
Affiliations
Purpose: To perform a genotype-phenotype correlation for three patients heterozygous for a missense mutation in the tissue inhibitor of metalloproteinase 3 (TIMP3) gene.
Methods: Retrospective, observational case series. The medical records and photographs were reviewed for three patients diagnosed at the time with neovascular age-related macular degeneration (AMD). All were later found to carry a predicted C113G mutation in the TIMP3 gene, other known mutations in which are associated with Sorsby's fundus dystrophy.
Results: All three patients developed drusen and bilateral choroidal neovascularisation with subsequent disciform scarring and atrophy. Visual acuity rapidly deteriorated to <6/60 in both eyes. The age of onset varied from 56 to 64 years and the interval to contralateral eye involvement varied from 4 to 6 years. Two of the three patients had a family history of AMD. All three patients were heterozygous for the C113G nucleotide change, resulting in a Ser38Cys change at the N terminus of the TIMP3 protein.
Conclusion: This case series suggests the C113G TIMP3 variant may represent a novel highly penetrant mutation causing choroidal neovascularisation of relatively late onset for Sorsby's fundus dystrophy, mimicking early onset AMD.
Genetic Insights into Age-Related Macular Degeneration.
Bhumika , Bora N, Bora P Biomedicines. 2024; 12(7).
PMID: 39062052 PMC: 11274963. DOI: 10.3390/biomedicines12071479.
Vergaro A, Pankievic M, Jedlickova J, Dudakova L, Vajter M, Michaelides M Int J Mol Sci. 2024; 25(7).
PMID: 38612555 PMC: 11011298. DOI: 10.3390/ijms25073744.
Review: Mechanisms of TIMP-3 accumulation and pathogenesis in Sorsby fundus dystrophy.
Betts J, Troeberg L Mol Vis. 2024; 30:74-91.
PMID: 38601018 PMC: 11006011.
Lynn S, Soubigou F, Dewing J, Smith A, Ballingall J, Sass T Int J Mol Sci. 2022; 23(23).
PMID: 36498929 PMC: 9736887. DOI: 10.3390/ijms232314603.
Potential CRISPR Base Editing Therapeutic Options in a Sorsby Fundus Dystrophy Patient.
Abdalla Elsayed M, Kaukonen M, Kiraly P, Cehajic Kapetanovic J, MacLaren R Genes (Basel). 2022; 13(11).
PMID: 36421778 PMC: 9690532. DOI: 10.3390/genes13112103.